Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Feb;11(2):244–247. doi: 10.1128/aac.11.2.244

Bone Marrow Toxicity Associated with 5-Fluorocytosine Therapy

Carol A Kauffman *, Peter T Frame 1
PMCID: PMC351961  PMID: 848928

Abstract

Bone marrow toxicity occurred in 4 of 15 patients treated with 5-fluorocytosine (5-FC) for serious fungal infections. The development of marrow toxicity appeared to be related to serum 5-FC levels of 125 μg/ml or greater. In three patients, accumulation of toxic levels of 5-FC was related to diminished renal function. One patient with acute renal failure and prolonged high levels of 5-FC developed marrow aplasia and died of bacterial sepsis. Three patients experienced leukopenia, which was readily reversed when the dosage of 5-FC was decreased and the serum concentration was lowered. With careful monitoring of serum 5-FC concentration and renal function, the dose-related toxic effects of 5-FC on the marrow can be avoided.

Full text

PDF
244

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Block E. R., Bennett J. E., Livoti L. G., Klein W. J., Jr, MacGregor R. R., Henderson L. Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man. Ann Intern Med. 1974 May;80(5):613–617. doi: 10.7326/0003-4819-80-5-613. [DOI] [PubMed] [Google Scholar]
  2. Davies R. R., Reeves D. S. 5-fluorocytosine and urinary candidiasis. Br Med J. 1971 Mar 13;1(5749):577–579. doi: 10.1136/bmj.1.5749.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gordon M. A., Vedder D. K. Serologic tests in diagnosis and prognosis of cryptococcosis. JAMA. 1966 Sep 19;197(12):961–967. [PubMed] [Google Scholar]
  4. Hamilton-Miller J. M. Chemistry and biology of the polyene macrolide antibiotics. Bacteriol Rev. 1973 Sep;37(3):166–196. [PMC free article] [PubMed] [Google Scholar]
  5. Kaspar R. L., Drutz D. J. Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B. Antimicrob Agents Chemother. 1975 Apr;7(4):462–465. doi: 10.1128/aac.7.4.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kauffman C. A., Carleton J. A., Frame P. T. Simple assay for 5-fluorocytosine in the presence of amphotericin B. Antimicrob Agents Chemother. 1976 Mar;9(3):381–383. doi: 10.1128/aac.9.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kauffman C. A., Tan J. S. Torulopsis glabrata renal infection. Am J Med. 1974 Aug;57(2):217–224. doi: 10.1016/0002-9343(74)90446-x. [DOI] [PubMed] [Google Scholar]
  8. Koechlin B. A., Rubio F., Palmer S., Gabriel T., Duschinsky R. The metabolism of 5-fluorocytosine-2-14-C and of cytosine-14-C in the rat and the disposition of 5-fluorocytosine-2-14-C in man. Biochem Pharmacol. 1966 Apr;15(4):435–446. doi: 10.1016/0006-2952(66)90254-1. [DOI] [PubMed] [Google Scholar]
  9. Medoff G., Kobayashi G. S. Amphotericin B. Old drug, new therapy.?2110. JAMA. 1975 May 12;232(6):619–620. doi: 10.1001/jama.232.6.619. [DOI] [PubMed] [Google Scholar]
  10. Record C. O., Skinner J. M., Sleight P., Speller D. C. Candida endocarditis treated with 5-fluorocytosine. Br Med J. 1971 Jan 30;1(5743):262–264. doi: 10.1136/bmj.1.5743.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Schlegel R. J., Bernier G. M., Bellanti J. A., Maybee D. A., Osborne G. B., Stewart J. L., Pearlman D. S., Ouelette J., Biehusen F. C. Severe candidiasis associated with thymic dysplasia, IgA deficiency, and plasma antilyMPHOCYTE EFFECTS. Pediatrics. 1970 Jun;45(6):926–936. [PubMed] [Google Scholar]
  12. Schönebeck J., Polak A., Fernex M., Scholer H. J. Pharmacokinetic studies on the oral antimycotic agent 5-fluorocytosine in individuals with normal and impaired kidney function. Chemotherapy. 1973;18(6):321–336. doi: 10.1159/000221279. [DOI] [PubMed] [Google Scholar]
  13. Shadomy S. In vitro studies with 5-fluorocytosine. Appl Microbiol. 1969 Jun;17(6):871–877. doi: 10.1128/am.17.6.871-877.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Utz J. P., Garriques I. L., Sande M. A., Warner J. F., Mandell G. L., McGehee R. F., Duma R. J., Shadomy S. Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. J Infect Dis. 1975 Oct;132(4):368–373. doi: 10.1093/infdis/132.4.368. [DOI] [PubMed] [Google Scholar]
  15. Wade D. N., Sudlow G. The kinetics of 5-fluorocytosine elimination in man. Aust N Z J Med. 1972 May;2(2):153–158. doi: 10.1111/j.1445-5994.1972.tb03925.x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES